A series of clinical trials focused on the use of ultrasound-guided platelet-rich plasma (PRP) infusions for the treatment of patients with carpal tunnel syndrome (CTS) were published over the last few years. However, the role of PRP for CTS remains unclear. We performed a systematic review according to Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. Two reviewers independently conducted the search using multiple databases: MEDLINE/PubMed, SCOPUS, Cochrane Database, and Web of Science. These databases were searched using terms “platelet” AND “rich” AND “plasma” AND “carpal” AND “tunnel”. To maximize the search, backward chaining of references from retrieved papers was also undertaken. From the initial 19 studies, only five met our eligibility criteria. These articles included one randomized controlled double-blind study, one randomized controlled single-blind study, one randomized controlled non-blind study, one case–control study, and one case report. The vast majority of the included studies supported that PRP infusion improved the clinical condition of the patients and that PRP infusion was beneficial for patients with mild-to-moderate CTS. Therefore, PRP seems to be an interesting alternative for the treatment of mild-to-moderate CTS which, still, has not been thoroughly investigated. However, despite the promising results of the present studies, PRP has to be further tested before we reach to a definite conclusion regarding its therapeutic value.
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
Giannessi E, Coli A, Stornelli MR, Miragliotta V et al (2014) An autologously generated platelet-rich plasma suturable membrane may enhance peripheral nerve regeneration after neurorrhaphy in an acute injury model of sciatic nerve neurotmesis. J Reconstr Microsurg 30(9):617–626CrossRefGoogle Scholar
Farrag TY, Lehar M, Verhaegen P, Carson KA, Byrne PJ (2007) Effect of platelet rich plasma and fibrin sealant on facial nerve regeneration in a rat model. Laryngoscope 117(1):157–165CrossRefGoogle Scholar
Park GY, Kwon DR (2014) Platelet-rich plasma limits the nerve injury caused by 10% dextrose in the rabbit median nerve. Muscle Nerve 49(1):56–60CrossRefGoogle Scholar
Piskin A, Kaplan S, Aktas A et al (2009) Platelet gel does not improve peripheral nerve regeneration: an electrophysiological, stereological, and electron microscopic study. Microsurgery 29(2):144–153CrossRefGoogle Scholar
Kaplan S, Piskin A, Ayyildiz M et al (2011) The effect of melatonin and platelet gel on sciatic nerve repair: an electrophysiological and stereological study. Microsurgery 31(4):306–313CrossRefGoogle Scholar
Elgazzar RF, Mutabagani MA, Abdelaal SE, Sadakah AA (2008) Platelet rich plasma may enhance peripheral nerve regeneration after cyanoacrylate reanastomosis: a controlled blind study on rats. Int J Oral Maxillofac Surg 37(8):748–755CrossRefGoogle Scholar
Sariguney Y, Yavuzer R, Elmas C, Yenicesu I, Bolay H, Atabay K (2008) Effect of platelet-rich plasma on peripheral nerve regeneration. J Reconstr Microsurg 24(3):159–167CrossRefGoogle Scholar
Shen YX, Fan ZH, Zhao JG, Zhang P (2009) The application of platelet-rich plasma may be a novel treatment for central nervous system diseases. Med Hypotheses 73(6):1038–1040CrossRefGoogle Scholar
Yu W, Wang J, Yin J (2011) Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury. Int J Neurosci 121(4):176–180CrossRefGoogle Scholar
Sanchez M, Anitua E, Delgado D et al (2016) Platelet-rich plasma, a source of autologous growth factors and biomimetic scaffold for peripheral nerve regeneration. Expert Opin Biol Ther 28:1–16Google Scholar
Chen YS, Murakami S, Gyo K, Wakisaka H, Matsuda S, Sakanaka M (1999) Effects of basic fibroblast growth factor (bfgf)-neutralizing antibody and platelet factor 4 on facial nerve regeneration. Exp Neurol 155:274–283CrossRefGoogle Scholar
Oya T, Zhao YL, Takagawa K et al (2002) Platelet-derived growth factor-b expression induced after rat peripheral nerve injuries. Glia 38:303–312CrossRefGoogle Scholar
McTigue DM, Popovich PG, Morgan TE, Stokes BT (2000) Localization of transforming growth factor-beta1 and receptor mrna after experimental spinal cord injury. Exp Neurol 163:220–230CrossRefGoogle Scholar
MacDermid JC, Doherty T (2004) Clinical and electrodiagnostic testing of carpal tunnel syndrome a narrative review. J Orthop Sports Phys Ther 34(10):565–588CrossRefGoogle Scholar
Lundborg G (1988) Intraneural microcirculation. Orthop Clin North Am 19(1):1–12Google Scholar
Gelberman RH, Rydevik BL, Pess GM, Szabo RM, Lundborg G (1988) Carpal tunnel syndrome. A scientific basis for clinical care. Orthop Clin North Am 19(1):115–124Google Scholar
Ettema AM, Amadio PC, Zhao C, Wold LE, An KN (2004) A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am 86A(7):1458–1466CrossRefGoogle Scholar
Hirata H, Nagakura T, Tsujii M (2004) The relationshiot of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome. J Pathol 205(5):606–612Google Scholar
Allampallam K, Chakraborty J, Robinson J (2000) Effect of ascorbic acid and growth factors on collagen metabolism of flexor retinaculum cells from individuals with and without carpal tunnel syndrome. J Occup Environ Med 42(3):251–259CrossRefGoogle Scholar
Anjayani S, Wirohadidjojo YW, Adam AM, Suwandi D, Seweng A, Amiruddin MD (2014) Sensory improvement of leprosy peripheral neuropathy in patients treated with perineural injection of platelet-rich plasma. Int J Dermatol 53(1):109–113CrossRefGoogle Scholar
Sanchez M, Yoshioka T, Ortega M, Delgado D, Anitua E (2014) Ultrasound-guided platelet-rich plasma injections for the treatment of common peroneal nerve palsy associated with multiple ligament injuries of the knee. Knee Surg Sports Traumatol Arthrosc 22(5):1084–1089CrossRefGoogle Scholar
Kuffler DP, Reyes O, Sosa IJ, Santiago-Figueroa J (2011) Neurological recovery across a 12-cm-long ulnar nerve gap repaired 3.25 years post trauma: case report. Neurosurgery 69(6):E1321–E1326CrossRefGoogle Scholar
Hibner M, Castellanos ME, Drachman D, Balducci J (2012) Repeat operation for treatment of persistent pudendal nerve entrapment after pudendal neurolysis. J Minim Invasive Gynecol 19(3):325–330CrossRefGoogle Scholar
Scala M, Mereu P, Spagnolo F, Massa M, Barla A, Mosci S et al (2014) The use of platelet-rich plasma gel in patients with mixed tumour undergoing superficial parotidectomy: a randomized study. In Vivo 28(1):121–124Google Scholar
Malahias MA, Nikolaou VS, Johnson EO, Kaseta MK, Kazas ST, Babis GC (2017) Platelet-rich plasma ultrasound-guided injection in the treatment of carpal tunnel syndrome: a Placebo-controlled clinical study. J Tissue Eng Regen Med. 12(3):e1480–e1488CrossRefGoogle Scholar
Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, Chen LC (2017) Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Sci Rep 7(1):94CrossRefGoogle Scholar
Raeissadat SA, Karimzadeh A, Hashemi M, Bagherzadeh L (2018) Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial. BMC Musculoskelet Disord 19(1):49CrossRefGoogle Scholar
Uzun H, Bitik O, Uzun Ö, Ersoy US, Aktaş E (2017) Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J Plast Surg Hand Surg 51(5):301–305CrossRefGoogle Scholar
Kuo YC, Lee CC, Hsieh LF (2017) Ultrasound-guided perineural injection with platelet-rich plasma improved the neurophysiological parameters of carpal tunnel syndrome: a case report. J Clin Neurosci 44:234–236CrossRefGoogle Scholar
Malahias MA, Johnson EO, Babis GC, Nikolaou VS (2015) Single injection of platelet-rich plasma as a novel treatment of carpal tunnel syndrome. Neural Regen Res 10(11):1856–1859CrossRefGoogle Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097CrossRefGoogle Scholar
Malahias M-A, Chytas D, Babis GC, Nikolaou VS (2014) Platelet-rich plasma guided injections: clinical application in peripheral neuropathies. Front Surg 1:41CrossRefGoogle Scholar